MYRIAD GENETICS INC. - COMMON STOCK

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

09 يناير 2025 16:30:00 بحسب Nasdaq GlobeNewswire

UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 يناير 2025 11:27:21 بحسب Nasdaq GlobeNewswire

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 يناير 2025 08:00:01 بحسب Nasdaq GlobeNewswire

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

07 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

06 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

19 ديسمبر 2024 16:15:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

19 ديسمبر 2024 09:46:28 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

18 ديسمبر 2024 09:58:51 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

17 ديسمبر 2024 10:07:50 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

13 ديسمبر 2024 09:46:22 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

12 ديسمبر 2024 09:45:26 بحسب NetDania Notify

Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing

10 ديسمبر 2024 18:26:39 بحسب Nasdaq GlobeNewswire

Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member

10 ديسمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics’ Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines

10 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium

09 ديسمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment

09 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

06 ديسمبر 2024 09:53:52 بحسب NetDania Notify

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

20 نوفمبر 2024 16:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

20 نوفمبر 2024 09:52:22 بحسب NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

19 نوفمبر 2024 10:20:58 بحسب NetDania Notify